Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma

Cancer Research

Volumn 62, Issue 14, 2002, Pages 3971-3979

  Sugita, Michio ^a   Geraci, Mark ^a   Gao, Bifeng ^a   Powell, Roger L ^a   Hirsch, Fred R ^a   Johnson, Gary ^a   Lapadat, Razvan ^a   Gabrielson, Edward ^b   Bremnes, Roy ^a   Bunn, Paul A ^a   Franklin, Wilbur A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b F S Key Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GENE PRODUCT;

ANTIGEN DETECTION; ARTICLE; BRONCHUS MUCOSA; COMPUTER PROGRAM; CONTROLLED STUDY; CTAG GENE; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; DNA MICROARRAY; EARLY DIAGNOSIS; GENE EXPRESSION REGULATION; GENE ISOLATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAGE A GENE; MAGE A1 GENE; MAGE A10 GENE; MAGE A12 GENE; MAGE A3 GENE; MAGE A4B GENE; MAGE A6 GENE; MESOTHELIOMA; NUCLEOTIDE SEQUENCE; NY ESO 1 GENE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TISSUE HOMOGENATE; VALIDATION PROCESS;

ANTIGENS, NEOPLASM; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TESTIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0037099668     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Revisions in the international system for staging lung cancer
2. Chemotherapy of lung cancer
3. Mass screening for lung cancer with mobile spiral computed tomography scanner
4. Early lung cancer action project: Overall design and findings from baseline screening
5. Early detection of lung cancer: Clinical perspectives of recent advances in biology and radiology
6. Clinical value of a multiple biomarker assay in patients with bronchogenic carcinoma
7. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: Prospective study in 621 patients
8. Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer
9. The tissue polypeptide antigen serum test in the preoperative evaluation of non-small cell lung cancer. Diagnostic yield and comparison with conventional staging methods
10. Cytokeratins as serum markers in lung cancer: A comparison of CYFRA 21-1 and TPS
11. Elevated plasma concentrations of C-flanking gastrin-releasing peptide in small-cell lung cancer
12. Serum neuronspecific enolase (S-NSE) in progressive small-cell lung cancer (SCLC)
13. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer
14. Chromogranin A as serum marker for neuroendocrine neoplasia: Comparison with neuronspecific enolase and the α-subunit of glycoprotein hormones
15. Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer
16. Anti-Hu antibodies in patients with small-cell lung cancer: Association with complete response to therapy and improved survival
17. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes
18. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation
19. Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: Association with improved survival
20. Expression monitoring by hybridization to high-density oligonucleotide arrays
21. A physical map of the human genome
22. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
23. Expansion of bronchial epithelial cell populations by in vitro culture of explants from dysplastic and histologically normal sites
24. One-step duplex reverse transcription-polymerase chain reaction for quantitative assessment of RNA degradation
25. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
26. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
27. Cancer-testis antigens: Targets for cancer immunotherapy
28. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
29. Structure, chromosomal localization, and expression of 12 genes of the MAGE family
30. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28
31. A family of rapidly evolving genes from the sex reversal critical region in Xp21
32. Expression of mRNA for three bombesin receptor subtypes in human bronchial epithelial cells
33. Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas
34. An overview of the MAGE gene family with the identification of all human members of the family
35. A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells
36. Identification of a new, unorthodox member of the MAGE gene family
37. The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region
38. Expression of MAGE and GAGE in high-grade brain tumors: A potential target for specific immunotherapy and diagnostic markers
39. Expression of cancer testis genes in human brain tumors
40. Zanovello GAGE gene expression in human rhabdomyosarcomas
41. MAGE BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia
42. Expression of gene MAGE-A4 in Reed-Sternberg cells
43. Cytolytic T lymphocytes raised against a human bladder carcinoma recognize an antigen encoded by gene MAGE-A12
44. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma
45. MAGE-A gene expression pattern in primary breast cancer
46. LAGE-1, a new gene with tumor specificity
47. Expression of MAGE-antigens in normal tissues and cancer
48. Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours
49. Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells
50. cDNA and protein characterization of human MAGE-10
51. Anti-MAGE-3 antibody 57B and anti-MAGE-1 antibody 6C1 can be used to study different proteins of the MAGE-A family
52. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis
53. The melanoma antigen genes-any clues to their functions in normal tissues?
54. Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: Comparative evaluation with neuron-specific enolase
55. Identification of a human achaetescute homolog highly expressed in neuroendocrine tumors
56. IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines
57. Key peptide processing enzymes are expressed by a variant form of small-cell carcinoma of the lung
58. Expression in human lung cancer cell lines of genes of prohormone processing and the neuroendocrine phenotype
59. Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells
60. Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer
61. PGP9.5 as a candidate tumor marker for non-small-cell lung cancer
62. Serial analysis of gene expression in non-small cell lung cancer
63. Significance of Na+ K(+)-ATPase on intracellular accumulation of cis- diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines
64. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma
65. Osteopontin expression in lung cancer
66. Diversity of gene expression in adenocarcinoma of the lung
67. Molecular characteristics of non-small cell lung cancer